Skip to main content

Featured

Tariff Costs Put New Pressure on U.S. Corporate Profits

Rising tariff expenses are beginning to weigh heavily on U.S. companies, prompting executives across multiple industries to warn that profit margins may tighten in the months ahead. Many firms had initially suggested they could manage the added costs through efficiency improvements or selective price increases, but that confidence is fading as import-related expenses continue to climb. Companies that rely on global supply chains are feeling the strain most acutely. Higher costs on imported materials and components are forcing difficult decisions: pass the increases on to consumers, risking weaker demand, or absorb the costs internally, which directly erodes profitability. For many businesses, neither option is attractive. Consumer-facing brands are finding it especially challenging to raise prices further, as shoppers show growing sensitivity to even modest increases. This resistance limits the ability of firms to offset tariff-driven expenses, creating a squeeze that is beginning t...

article

Young-onset dementia: A growing public health concern in Canada

 

Young-onset dementia is a growing public health concern in Canada. According to the Alzheimer Society of Canada, the number of individuals impacted is projected to reach more than 40,000 people by 2050.

The diagnosis of dementia in individuals under the age of 65 is referred to as “young onset dementia” and poses unique challenges. Diagnoses are often delayed, and it’s tough to get workplace accommodations.

The reasons behind the rise of young-onset dementia in Canada are not yet fully understood. However, the latest landmark study by the Alzheimer’s Society of Canada suggests that a growing number of Canadians are developing dementia in their 60s, 50s, 40s, and even earlier. The study highlights that the initial diagnosis of young-onset dementia is often incorrect, leading to delayed diagnoses and missed opportunities for early intervention.


Comments